Clinical Trial Update: Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of sorafenib, valproic acid, and sildenafil in patients with recurrent high-grade glioma has completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma
• Who Grade Iii Glioma

Drugs mentioned

• Nexavar (Sorafenib)
• VALPROIC ACID (Valproic acid)
• Viagra (Sildenafil)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Glioblastoma, Recurrent Adult Brain Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2021-10-28